Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

China health stocks slammed as investors fear regulators' diagnosis

07/28/2021 | 04:45am EDT
Investors look at computer screens showing stock information at a brokerage in Shanghai

SHANGHAI (Reuters) - Investors have rushed to exit bets on China's health sector this week, fearing that a regulatory crackdown that sparked panic selling in the tech and education sectors might hit the medical industry next.

Medical expenses are one of three key areas of living costs seen as Beijing's targets for social change, heightening expectations that authorities will make healthcare their next focus of market reform.

"Real estate, education, and healthcare are the three big mountains and the government inevitably has to tackle the issues," said Ming Liao, founding partner of Beijing-based private equity firm Prospect Avenue Capital.

Selling has been fierce and although the Hang Seng healthcare index bounced 7% on Wednesday, it is still down about 11% for the week compared with a similar drop in the hard-hit Hang Seng Tech index and a 7.2% week-so-far plunge in the broader Hang Seng index.

Among mainland China stocks, the CSI300 Healthcare index was in freefall from last Thursday until it steadied on Wednesday, shedding roughly 13% in the process, trailing a 20% fall suffered by education stocks but outstripping the broader market.

"I think obviously (small investors) have panicked," said Andy Maynard, head of equities at China Renaissance in Hong Kong, who feels the rout may have been a bit overdone.

Graphic: China healthcare follows tech lower -

Among the worst hit stocks are those with a tech overlap: JD Health International, Alibaba Health Information Technology and Genscript Biotech Corp., racked up losses between 27% and 36% over the past five days.

China's health sector is vast, comprising defensive service providers, pharmaceuticals and fast-growing tech and biotech firms, though it had been seen as exposed to big demographic trends and supported by rising public and private spending.

Reforms over the past decade have sought to expand social health insurance, public procurement of medicine and hospital building. Last month, China's State Council, or cabinet, promised further progress on medicine prices.

Huang Yan, vice president of Shanghai See Truth Investment Management, said the government would likely take a targeted approach to tackling different parts of the sector in its drive for social reform.

"Sectors like cosmetic medicine consume wealth but create little social value," he said. "But the government will continue to support innovative drugmaking, while reducing drug prices through bulk-buying."

Still, while costs remain high and quality of care has been an issue outside big cities, analysts are nervous about where the authorities' next move lands.

"The jittery...search for the next shoe to drop may keep investors away from engaging for now," said Tommy Xie, OCBC Bank's head of greater China research.

(Reporting by Samuel Shen and Andrew Galbraith in Shanghai; Writing and additional reporting by Tom Westbrook; Editing by Vidya Ranganathan and Sam Holmes)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
GENSCRIPT BIOTECH CORPORATION -1.65% 32.7 End-of-day quote.189.89%
JD HEALTH INTERNATIONAL INC. -6.63% 71.8 End-of-day quote.-52.13%
Latest news "Economy & Forex"
06:10aIndonesia court finds president negligent in air pollution lawsuit
RE
06:02aUK's M&S to close 11 stores in France after Brexit
RE
06:00aFrance's Thales keeps 2021 goals after contract blow
RE
06:00aWITH OR WITHOUT YOU - 'EXCHINA' IN VOGUE? : Mike Dolan
RE
05:58aSWISS WATCHDOG FINMA : banks' syndicated loans falling behind LIBOR transition
RE
05:57aHungary eases repayment rules for some loans under moratorium
RE
05:55aUK's Virgin Media-O2 to launch IPTV by end of the year
RE
05:51aANALYSIS : India may corner nearly half of global rice trade as exports soar to record
RE
05:51aSingapore fuel oil stocks drop despite net imports rising to over 1-year high
RE
05:47aMalaysia says auditor KPMG to pay $80 million in 1MDB settlement
RE
Latest news "Economy & Forex"